MLXIPL and hepatocellular carcinoma: It appears that Flii acts as a component of the glucose-responsive transcription factor carbohydrate responsive element binding protein (ChREBP) transcription complex, colocalising to interact with ChREBP and down regulate ChREBP-mediated transcription in colorectal cancer and hepatocellular carcinoma cells (Wu et al., 2013).